Pharmaceutical compositions of lithium compounds to treat presenile or senile dementia
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 28, 1988
Grant Date -
N/A
app pub date -
Jan 27, 1987
filing date -
Jan 27, 1986
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
This invention relates to the treatment of presenile or sensile dementia and in particular to the treatment of Alzheimer's disease. It is proposed that such conditions may be combatted or their effects alleviated by the administration of a physiologically acceptable lithium compound and/or of an essential fatty acid or a physiologically acceptable salt thereof and there are described herein methods of treatment of such conditions.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully